Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 517 entries
View as:

A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT03603132 Org: User:
Start: 07/14/18 End: 08/17/18 Due: 08/17/19

A Trial of SHR7280 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06969664 Org: User:
Start: 05/31/25 End: 06/30/25 Due: 06/30/26

The Drug-drug Interaction of SHR3824 and Metformin

Phase: N/A Priority: Normal
NCT ID: NCT02354027 Org: User:
Start: 09/30/14 End: 01/31/15 Due: 01/31/16

A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Transporter Pgp Substrate Digoxin in Advanced Solid Tumor Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04322552 Org: User:
Start: 03/12/20 End: 05/03/21 Due: 05/03/22

A Trial of SHR-1802 in Patients With Failure of Standard Treatment for Advanced Malignant Tumours

Phase: N/A Priority: Normal
NCT ID: NCT04414150 Org: User:
Start: 06/17/20 End: 03/15/22 Due: 03/15/23

Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03159052 Org: User:
Start: 06/30/17 End: 06/30/19 Due: 06/30/20

The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03182673 Org: User:
Start: 07/24/17 End: 06/12/19 Due: 06/12/20

A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine Fibroids

Phase: N/A Priority: Normal
NCT ID: NCT05442827 Org: User:
Start: 09/10/22 End: 06/01/26 Due: 06/01/27

A Study of Famitinib Plus Docetaxel in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT02364362 Org: User:
Start: 01/31/15 End: 12/31/18 Due: 12/31/19

A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT06015048 Org: User:
Start: 08/11/23 End: 12/29/26 Due: 12/29/27

A PHASE I, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE DOSE ESCALATION STUDY TO INVESTIGATE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SHR0534 IN HEALTHY VOLUNTEERS

Phase: N/A Priority: Normal
NCT ID: NCT02749097 Org: User:
Start: 10/31/13 End: - Due: -

Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

Phase: N/A Priority: Normal
NCT ID: NCT05513976 Org: User:
Start: 09/15/22 End: 09/20/23 Due: 09/20/24

A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03710681 Org: User:
Start: 08/02/18 End: 07/30/19 Due: 07/30/20

A Study of SHR-A1811 in Subjects With Gynaecologic Oncology

Phase: N/A Priority: Normal
NCT ID: NCT05896020 Org: User:
Start: 07/10/23 End: 06/15/26 Due: 06/15/27

A Trial of SHR0410 Injection for the Treatment of Pain After Endoscopic Surgery of the Lower Abdominal

Phase: N/A Priority: Normal
NCT ID: NCT04852003 Org: User:
Start: 05/13/21 End: 07/22/21 Due: 07/22/22

A Drug-drug Interaction Trial to Evaluate the Pharmacokinetics Effect of Rifampicin on Famitinib

Phase: N/A Priority: Normal
NCT ID: NCT04494659 Org: User:
Start: 07/20/20 End: 08/31/20 Due: 08/31/21

Efficacy and Safety of SP2086 as Monotherapy in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01970033 Org: User:
Start: 12/31/12 End: 01/31/15 Due: 01/31/16

A Phase I Study of SHR1459 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04455100 Org: User:
Start: 07/17/20 End: 08/14/20 Due: 08/14/21

Effect of Rifampicin on the Pharmacokinetics of SHR6390 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04439578 Org: User:
Start: 06/23/20 End: 01/15/21 Due: 01/15/22

A Trial of HRS-6768 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06925581 Org: User:
Start: 04/24/25 End: 04/30/27 Due: 04/30/28

Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06710990 Org: User:
Start: 02/17/25 End: 08/31/26 Due: 08/31/27

Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in Patients With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT04885218 Org: User:
Start: 07/30/21 End: 05/23/23 Due: 05/23/24

A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01503502 Org: User:
Start: 08/31/11 End: 12/31/14 Due: 12/31/15

A Drug-drug Interaction Study of SHR2150 on Healthy Chinese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05141422 Org: User:
Start: 12/13/21 End: 01/22/22 Due: 01/22/23

A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted Sedation

Phase: N/A Priority: Normal
NCT ID: NCT05015361 Org: User:
Start: 05/07/21 End: 07/04/21 Due: 07/04/22